Hatch-Waxman Act Updates in 2014
Overview:
As pharmaceutical companies and related agencies continue to litigate in the dynamic Hatch-Waxman Act environment; recent developments in case law, further impact from the America Invents Act as well as agency enforcement activity will make for a complex year of developments. To better understand the issues and dynamics involving strategic alliances in the pharmaceutical industry, business leaders and their legal counsel must understand the legal and financial factors to help them better anticipate outcomes under this area of developing law.A panel of thought leaders and practitioners assembled by the Knowledge Group will discuss the significant topics relating to current Hatch-Waxman Act issues, including enforcement and compliance, from a both a legal and finance perspective providing attendees with leading practices to help avoid the many pitfalls. Hatch-Waxman Act Updates in 2014 LIVE Webcast is a must attend live webcast for all professionals working in the antitrust area and in the pharmaceutical industry.
Agenda:
Yogesh Bahl, Managing Director, FAS
AlixPartners
- Finance/economics perspective and strategies that corporations must consider
- Offer a new point of view
Brendan P. Glackin, Partner
Lieff Cabraser Heimann & Bernstein, LLP
Reverse payment cases in antitrust
- Pre-Actavis: Dominance of the “Scope of the Patent” Standard
- Post-Actavis:
- Rule of Reason Incorporating Inquiry into Size and “Purpose” of Reverse Payment
- Extent to Which Validity of Patent Matters
- Possibility of Preemption of State Remedies and State Court Jurisdiction
- How do you try an Actavis claim?
- Overview of reverse-payment cases filed in the wake of Actavis .
Ha Kung Wong, Partner
Fitzpatrick, Cella, Harper & Scinto
- Historical perspective
- Impact of ITR’S and TGR’S
William Coppola, Senior Patent Counsel
Sanofi-Aventis
- Licensing issues and litigation – who’ll control litigation. Licensees lack power.
Who Should Attend:
- General Counsel in the life sciences and healthcare industries
- Compliance, Privacy and Data Security Officers
- Biotech/Pharma/Healthcare Attorneys & Advisors
- Life Sciences and Health Care Practice Consultants/Advisors
- Consultants & Clients in the Biotech, Pharmaceutical and Healthcare Industries
- Other related and interested professionals
Yogesh Bahl is a Managing Director in AlixPartners’ Financial Advisory Services practice and leads its life sciences efforts. He has …
Brendan is a dedicated antitrust and securities fraud litigator, who possesses a wealth of litigation and trial experience as a …
Ha Kung Wong is a partner at Fitzpatrick, Cella, Harper & Scinto and practices general intellectual property law with an …
William Coppola has over 20 years of experience representing numerous clients, including universities, regarding a wide spectrum of patent and …
Course Level:
Intermediate
Advance Preparation:
Print and review course materials
Method of Presentation:
On-demand Webcast (CLE)
Prerequisite:
NONE
Course Code:
134514
Total Credits:
2.0 CLE
Login Instructions:
No Access
You are not logged in. Please Login or register to the event to gain access to the materials and login instructions.
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
Get Your 1-Year All Access Pass For Only $199
SPEAKERS' FIRMS:
Lieff Cabraser Heimann & Bernstein, LLP
About AlixPartners
AlixPartners, LLP (www.alixpartners.com) is a global business advisory firm offering comprehensive services in four major areas: enterprise improvement, turnaround and restructuring, financial advisory services and information management services. With offices located throughout Europe, the United States, and Middle East and Asia, we respond to urgent situations in real-time. Since 1981, we have taken a unique, small-team action-oriented approach to helping corporate boards and management, law firms, investment banks and investors respond to critical business issues. Our Financial Advisory Services professionals include accounting, forensic and valuation experts who assist companies and their legal counsel in urgent, high stakes disputes, litigation and investigations
Website: https://www.alixpartners.com/
About Lieff Cabraser Heimann & Bernstein, LLP
Lieff Cabraser Heimann & Bernstein, LLP, with offices in San Francisco, New York, and Nashville, is a nationally recognized law firm committed to advancing the rights of investors and promoting corporate responsibility. Since 2003, the National Law Journal has selected Lieff Cabraser as one of the top plaintiffs' law firms in the nation. In compiling the list, the National Law Journal examined recent verdicts and settlements in addition to overall track records. Lieff Cabraser is one of only two plaintiffs' law firms in the United States to receive this honor for the last eleven consecutive years.
Website: https://www.lieffcabraser.com/
About Fitzpatrick, Cella, Harper & Scinto
At Fitzpatrick, IP is not just a practice area – it is our sole focus. We cover the spectrum of intellectual property services to clients from virtually every industry and have one of the premier patent litigation practices and consistently appear in the list of top patent prosecution firms. Recently the firm was named the 2013 US IP Specialty Firm of the Year by Managing Intellectual Property magazine.
Our practice is dedicated exclusively to intellectual property (“IP”), and we cover the spectrum of intellectual property services, including applying for protection, litigation, appeals, interferences, reexaminations, alternative dispute resolution, licensing, opinions, corporate transactions and due diligence. The firm provides these services to clients from virtually every industry, including aerospace, automotive, biotechnology, chemicals, computers, consumer goods, electronics, energy, financial services, industrial equipment, manufacturing, marine, medical devices, nanotechnology, networks, pharmaceuticals, software, semiconductor technologies and telecommunications. As new technologies emerge, the firm is at the forefront in developing strategies for their intellectual property protection. Over 95% of the firm’s attorneys hold scientific or technical degrees and many also have substantial industry experience in various fields of technology including chemistry, biotechnology, pharmaceuticals, software and computers.
Our offices in New York, Washington D.C. and Orange County, California, serve a diverse national and international clientele from start-ups to Fortune 500 companies.
Website: https://www.fitzpatrickcella.com/
About Sanofi-Aventis
Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
Website: https://www.sanofi.us/